PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 6.99

Change

-0.05 (-0.71)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.97 (-3.11%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le..

-4.39 (-0.72%)

USD 7.96B
QLD ProShares Ultra QQQ

+0.02 (+0.02%)

USD 7.84B
SSO ProShares Ultra S&P500

+0.17 (+0.18%)

USD 5.60B
UPRO ProShares UltraPro S&P500

+0.24 (+0.27%)

USD 4.27B
TECL Direxion Daily Technology Bull..

-0.06 (-0.07%)

USD 3.43B
YINN Direxion Daily FTSE China Bull..

-0.37 (-1.44%)

USD 1.61B
USD ProShares Ultra Semiconductors

-0.43 (-0.62%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+0.47 (+0.50%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

-1.76 (-1.79%)

USD 0.82B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.55% 16% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.55% 16% F 18% F
Trailing 12 Months  
Capital Gain -15.38% 12% F 14% F
Dividend Return 0.94% 40% F 12% F
Total Return -14.43% 11% F 12% F
Trailing 5 Years  
Capital Gain -72.39% 18% F 5% F
Dividend Return 1.11% 16% F 3% F
Total Return -71.29% 18% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 57.79% 81% B- 94% A
Dividend Return 58.35% 79% B- 94% A
Total Return 0.56% 38% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 392.90% 15% F 3% F
Risk Adjusted Return 14.85% 25% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.